AstraZeneca and Handa Pharmaceuticals have agreed to pay a combined $51.4 million to resolve a class action lawsuit that claimed they unlawfully delayed the availability of cheaper generic versions of AstraZeneca’s antipsychotic drug.
The lawsuit ...
↧